Ursula Winterfeld

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


72 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS).
Onken M., Lohse L., Coulm B., Beghin D., Richardson J.L., Bermejo-Sánchez E., Aguilera C., Bosch M., Cassina M., Chouchana L. et al. Acta psychiatrica Scandinavica. Peer-reviewed.
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.
Favre G., Richardson J.L., Moore A., Geissbühler Y., Jehl V., Oliver A., Shechtman S., Diav-Citrin O., Berlin M., De Haan T. et al., 2024/03. Drug safety, 47 (3) pp. 227-236. Peer-reviewed.
Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project.
van Rijt-Weetink YRJ, Egberts TCG, van Hunsel FPAM, Lewis D.J., Yates L.M., Winterfeld U., van Puijenbroek E.P., 2024/03. Drug safety, 47 (3) pp. 261-270. Peer-reviewed.
Pregnancy outcomes after GLP-1 agonist exposure in early pregnancy
Winterfeld Ursula, Dao Kim, Haefliger David, Diezi Léonore, Girardin François, 2023/11/23. Swissmedic Vigilance News. Peer-reviewed.
 
Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
Cardoso E., Monfort A., Ferreira E., Fischer Fumeaux C.J., Henriot I., Winterfeld U., Gandia P., Guidi M., Panchaud A., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1940-1947. Peer-reviewed.
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort.
Favre G., Maisonneuve E., Pomar L., Daire C., Monod C., Martinez de Tejada B., Quibel T., Todesco-Bernasconi M., Sentilhes L., Blume C. et al., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1306-1312. Peer-reviewed.
Elements to assess the quality of information of case reports in pregnancy pharmacovigilance data—a ConcePTION project
van Rijt-Weetink Yrea R. J., Chamani Khoezik, Egberts Antoine C. G., van Hunsel Florence P. A. M., Lewis David J., Yates Laura M., Winterfeld Ursula, van Puijenbroek Eugène P., 2023/06/29. Frontiers in Drug Safety and Regulation, 3.
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.
Richardson J.L., Moore A., Bromley R.L., Stellfeld M., Geissbühler Y., Bluett-Duncan M., Winterfeld U., Favre G., Alexe A., Oliver A.M. et al., 2023/05. Drug safety, 46 (5) pp. 479-491. Peer-reviewed.
 
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Favre G., Gerbier E., Maisonneuve E., Pomar L., Winterfeld U., Lepigeon K., Bloemenkamp KWM, de Bruin O., Eimir H., Nordeng H. et al., 2023/05. British journal of clinical pharmacology, 89 (5) pp. 1560-1574. Peer-reviewed.
 
Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.
Maisonneuve E., Gerbier E., Tauqeer F., Pomar L., Favre G., Winterfeld U., Passier A., Oliver A., Baud D., Nordeng H. et al., 2023/04/29. Viruses, 15 (5) p. 1090. Peer-reviewed.
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
Favre G., Maisonneuve E., Pomar L., Daire C., Poncelet C., Quibel T., Monod C., Martinez de Tejada B., Schäffer L., Papadia A. et al., 2023/03. The Lancet regional health. Europe, 26 p. 100569. Peer-reviewed.
Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort.
Gerbier E., Favre G., Maisonneuve E., Ceulemans M., Winterfeld U., Dao K., Schmid CPR, Jenkinson S.P., Niznik B., Baud D. et al., 2023. Journal of diabetes research, 2023 p. 4105993. Peer-reviewed.
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis.
Abolhassani N., Winterfeld U., Kaplan Y.C., Jaques C., Minder Wyssmann B., Del Giovane C., Panchaud A., 2023/01. BMJ open diabetes research & care, 11 (1) pp. e002919. Peer-reviewed.
 
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Cardoso E., Monfort A., Ferreira E., Nordeng H., Winterfeld U., Allegaert K., Gandia P., Guidi M., Panchaud A., 2023. Therapie, 78 (2) pp. 149-156. Peer-reviewed.
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy: A Comparative ENTIS Cohort Study.
Dao K., Shechtman S., Diav-Citrin O., George N., Richardson J.L., Rollason V., Pistelli A., Eleftheriou G., Berlin M., Ekobena P. et al., 2023. Journal of clinical psychopharmacology, 43 (1) pp. 12-19. Peer-reviewed.
Mental health in pregnant individuals during the COVID-19 pandemic based on a Swiss online survey.
Favre G., Kunz C., Schwank S., Chung H.F., Radan A.P., Raio L., Fluri M., Winterfeld U., Baud D., Pomar L., 2022/11/02. Scientific reports, 12 (1) p. 18448. Peer-reviewed.
 
Queries on medication use during pregnancy: An analysis of data from the Swiss Teratogen Information Service
Baumgartner R., Winterfeld U., Panchaud A., Simoes-Wüst A.P., 2022/09., ENTIS 33rd Conference dans Neurotoxicology and Teratology.
Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".
Ceulemans M., Sillis L., Foulon V., Panchaud A., Winterfeld U., Pomar L., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/08. Journal of reproductive immunology, 152 p. 103639. Peer-reviewed.
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
Favre G., Maisonneuve E., Pomar L., Winterfeld U., Daire C., Martinez de Tejada B., Delecraz D., Campelo S., Moser M., Todesco-Bernasconi M. et al., 2022/07. The Lancet regional health. Europe, 18 p. 100410. Peer-reviewed.
Queries on medication use during pregnancy: characterisation of the Swiss Teratogen Information Service database.
Baumgartner R., Winterfeld U., Panchaud A., Simões-Wüst A.P., 2022/05/23. Swiss medical weekly, 152 pp. w30187. Peer-reviewed.
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D. et al., 2022/04/27. International journal of environmental research and public health, 19 (9) p. 5335. Peer-reviewed.
Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbek D., Spoendlin J. et al., 2022/01/27. International journal of environmental research and public health, 19 (3) p. 1456. Peer-reviewed.
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/01/26. International journal of environmental research and public health, 19 (3) p. 1389. Peer-reviewed.
Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbeki D., Spoendlin J. et al., 2021/11/22. Swiss medical weekly, 151 pp. w30048. Peer-reviewed.
 
Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
Vlenterie R., van Gelder MMHJ, Anderson H.R., Andersson L., Broekman BFP, Dubnov-Raz G., El Marroun H., Ferreira E., Fransson E., van der Heijden FMMA et al., 2021/10/01. Obstetrics and gynecology, 138 (4) pp. 633-646. Peer-reviewed.
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss Medical Weekly, 151 pp. w30009. Peer-reviewed.
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss medical weekly, 151 pp. w30009. Peer-reviewed.
 
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199".
Stuckelberger S., Favre G., Ceulemans M., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/08/05. Viruses, 13 (8) p. 1546. Peer-reviewed.
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional study.
Ceulemans M., Foulon V., Ngo E., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A. et al., 2021/07. Acta obstetricia et gynecologica Scandinavica, 100 (7) pp. 1219-1229. Peer-reviewed.
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
Stuckelberger S., Favre G., Ceulemans M., Nordeng H., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A. et al., 2021/06/22. Viruses, 13 (7) p. 1199. Peer-reviewed.
Cancer du sein chez la femme en [Breast cancer during pregnancy]
Schnetz M., Stravodimou A., Cisarovsky C., Dunand A., Prior J.O., Nicod Lalonde M., Baud D., Meuwly J.Y., Winterfeld U., Zaman K., 2021/05/19. Revue medicale suisse, 17 (739) pp. 957-961. Peer-reviewed.
Vaccine Willingness and Impact of the COVID-19 Pandemic on Women's Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2021/03/24. International journal of environmental research and public health, 18 (7) p. 3367. Peer-reviewed.
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
Valproate in pregnancy: authors' reply.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Ruegg S., Meier C., Winterfeld U., Panchaud A., 2021/02/15. Swiss medical weekly, 151 pp. w20481. Peer-reviewed.
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Rüegg S., Meier C., Winterfeld U., Panchaud A., 2021/01/01. Swiss medical weekly, 151 pp. w20386. Peer-reviewed.
An international registry for emergent pathogens and pregnancy.
Panchaud A., Favre G., Pomar L., Vouga M., Aebi-Popp K., Baud D., COVI-Preg group, 2020/05/09. Lancet, 395 (10235) pp. 1483-1484. Peer-reviewed.
 
Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study.
Weber-Schoendorfer C., Kayser A., Tissen-Diabaté T., Winterfeld U., Eleftheriou G., Te Winkel B., Diav-Citrin O., Greenall A., Hoeltzenbein M., Schaefer C., 2020/01. Journal of hypertension, 38 (1) pp. 133-141. Peer-reviewed.
 
Stabilizing cumulative incidence estimation of pregnancy outcome with delayed entries.
Rousson V., Allignol A., Aurousseau A., Winterfeld U., Beyersmann J., 2019/09. Biometrical journal. Biometrische Zeitschrift, 61 (5) pp. 1290-1302. Peer-reviewed.
 
Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis.
Winterfeld Ursula, 2019/03/01. Journal of acquired immune deficiency syndromes (1999).
 
Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).
Winterfeld U., Weber-Schöndorfer C., Schaefer C., von Elm E., Buclin T., 2018/09. Reproductive toxicology, 80 pp. 68-72. Peer-reviewed.
 
Antiepileptika in der Stillzeit : Wie beraten wir die Mütter? [Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]
Crettenand M., Rossetti A.O., Buclin T., Winterfeld U., 2018/08. Der Nervenarzt, 89 (8) pp. 913-921. Peer-reviewed.
 
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.
Panchaud A., Rousson V., Vial T., Bernard N., Baud D., Amar E., De Santis M., Pistelli A., Dautriche A., Beau-Salinas F. et al., 2018/03. British journal of clinical pharmacology, 84 (3) pp. 568-578. Peer-reviewed.
 
Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
Marzolini C., Decosterd L., Winterfeld U., Tissot F., Francini K., Buclin T., Livio F., 2017/12. British journal of clinical pharmacology, 83 (12) pp. 2835-2838. Peer-reviewed.
 
Nonparametric estimation of pregnancy outcome probabilities
Friedrich Sarah, Beyersmann Jan, Winterfeld Ursula, Schumacher Martin, Allignol Arthur, 2017/06/01. The Annals of Applied Statistics, 11 (2).
 
Pregnancy outcome following maternal exposure to pregabalin may call for concern.
Winterfeld U., Merlob P., Baud D., Rousson V., Panchaud A., Rothuizen L.E., Bernard N., Vial T., Yates L.M., Pistelli A. et al., 2016/06/14. Neurology, 86 (24) pp. 2251-2257. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
 
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C., 2016. Respiration; international review of thoracic diseases, 91 (4) pp. 333-348. Peer-reviewed.
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
 
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E. et al., 2015/06. Journal of Clinical Psychopharmacology, 35 (3) pp. 250-259. Peer-reviewed.
 
Médicaments, grossesse et lactation.
Delaloye J.F., Panchaud A., Weisskopf E., Winterfeld U., Rothuizen L., Vial Y., Csajka C., Buclin T., Hohlfeld P., 2015/01., 4e éd. 252 p, Médecine et Hygiène.
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.
 
Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique [Pharmacokinetic Alterations in Pregnancy and Use of Therapeutic Drug Monitoring].
Panchaud A., Weisskopf E., Winterfeld U., Baud D., Guidi M., Eap C.B., Csajka C., Widmer N., 2014. Therapie, 69 (3) pp. 223-234. Peer-reviewed.
 
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Weber-Schoendorfer C., Chambers C., Wacker E., Beghin D., Bernard N., Network of French Pharmacovigilance Centers, Shechtman S., Shechtman S., Johnson D., Cuppers-Maarschalkerweerd B. et al., 2014. Arthritis and Rheumatology, 66 (5) pp. 1101-1110.
 
Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey.
Csajka C., Jaquet A., Winterfeld U., Meyer Y., Einarson A., Panchaud A., 2014. Swiss Medical Weekly, 144 pp. w13936.
 
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (11) p. 1440.
Pregnancy outcome following maternal exposure to Mirtazapine: Preliminary results of a collaborative ENTIS study.
Winterfeld U., Buclin T., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., te Winkel B., Clementi M., Pistelli A. et al., 2013. pp. e1-e2 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
 
Management of deficient lactation in Switzerland and Canada: a survey of midwives' current practices.
Winterfeld U., Meyer Y., Panchaud A., Einarson A., 2012. Breastfeeding Medicine, 7 pp. 317-318.
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
 
Evaluation of risk perception related to drug use during pregnancy: a swiss survey
Jaquet A., Winterfeld U, Meyer Y., Buclin T., Csajka C., Panchaud A., 2011/02. p. 260 dans Reproductive Toxicology. Peer-reviewed.
 
Evaluation of risk perception related to drug use during pregnancy: a Swiss survey
Jaquet A., Winterfeld U., Meyer Y., Buclin T., Csajka C., Panchaud A., 2011. pp. 422-423 dans 39th ESCP European Symposium on Clinical Pharmacy and 13th SFPC Congress: Clinical Pharmacy at the Front Line of Innovations, International Journal of Clinical Pharmacy. Peer-reviewed.
 
Pregnancy outcome following maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 32 dans 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, British Journal of Clinical Pharmacology. Peer-reviewed.
 
Pregnancy Outcome Following Maternal Exposure To Statins: A Multicenter Prospective Study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 142 dans 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Basic & Clinical Pharmacology & Toxicology. Peer-reviewed.
 
Anwendung von Galaktogoga in der Schweiz.
Meyer Y., Winterfeld U., Panchaud A., 2010/05. Hebamme 5 pp. 4-9. Peer-reviewed.
Anwendung von Galaktogoga in der Schweiz
Meyer Y., Winterfeld U., Panchaud A., 2010. Hebamme.ch = Sage-femme.ch 5 pp. 4-9. Peer-reviewed.
 
Pregnancy outcome after maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A., Berlin M. et al., 2010. dans 21st Annual Meeting of the European Network Teratogen Information Services (ENTIS).
 
[Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld Ursula, 2009/07/28. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
 
Méthylphénidate et abus
Livio F., Rauber-Lüthy C., Biollaz J., Holzer L., Winterfeld U., Buclin T., 2009. Paediatrica : Bulletin der Schweizerischen Gesellschaft für Pädiatrie (SGP) = Bulletin de la Société suisse de pédiatrie (SSP), 20 (5) pp. 41-44.
 
Pratique en cas de lactogénèse insuffisante
Meyer Yvonne, Winterfeld Ursula, Panchaud Alice, 2009. Hebamme.ch = Sage-femme.ch, 2009 (10) pp. 40-45.
 
The use of prn medication in a child and adolescent mental health inpatient service in France.
Winterfeld Ursula, 2009/01/01. International journal of psychiatry in clinical practice.
 
Psychotropic medication use in the child and adolescent psychiatry wards of a French hospital.
Winterfeld Ursula, 2008/05/21. Pharmacy world & science : PWS.
 
Comparison of pain management in paediatric surgical patients in two hospitals in France and Canada.
Winterfeld Ursula, 2007/10/18. Pharmacy world & science : PWS.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University